Abyholm T, Tanbo T, Dale P O, Magnus O
Department of Obstetrics and Gynecology, National Hospital, University of Oslo, Norway.
J Assist Reprod Genet. 1992 Feb;9(1):19-23. doi: 10.1007/BF01204109.
This prospective study was undertaken to evaluate the relative efficacy of three in vivo methods of assisted fertilization in 150 infertile women with patent fallopian tubes: gamete intrafallopian transfer (GIFT), combined intrauterine and direct intraperitoneal insemination (IUI+DIPI), and controlled hyperstimulation (COHS) alone. The clinical pregnancy rate was highest in the IUI/DIPI and GIFT groups: IUI/DIPI, 29.3%; GIFT, 28.6%; and COHS, 8.9%. We believe that controlled ovarian hyperstimulation combined with IUI and DIPI is a good alternative to GIFT.
本前瞻性研究旨在评估三种体内辅助受精方法对150名输卵管通畅的不孕妇女的相对疗效:配子输卵管内移植(GIFT)、宫内与直接腹腔内联合授精(IUI+DIPI)以及单纯控制性超促排卵(COHS)。IUI/DIPI组和GIFT组的临床妊娠率最高:IUI/DIPI组为29.3%;GIFT组为28.6%;COHS组为8.9%。我们认为,控制性卵巢刺激联合IUI和DIPI是GIFT的良好替代方法。